Clinical Trials Directory

Trials / Completed

CompletedNCT04769700

Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19

Post-partum Depression, Breastfeeding Adherence, and Fear in Women Giving Birth During the COVID-19 Pandemic.

Status
Completed
Phase
Study type
Observational
Enrollment
250 (actual)
Sponsor
Instituto Mexicano del Seguro Social · Other Government
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to explore whether quarantine measures, social distancing and hospital containment policies among women giving birth during the COVID-19 pandemic enhanced psycho-emotional distress in the immediate postpartum period. The investigators tested for depression using the Edinburgh Postnatal Depression Scale (EPDS) in the first 6 postpartum months, and then used the Fear of COVID-19 Scale, measuring also the adherence and practices of breastfeeding according to WHO.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEdinburgh Postnatal Depression ScaleThe Edinburgh Postnatal Depression Scale is a self-administered questionnaire made up of 10 items scored using a four-point Likert scale (0-3) designed to screen for symptoms of postpartum depression. Postpartum depression represents the end of a continuum of severity of symptoms. The present study used a cutoff point for depressive symptomatology risk of higher than 12.
BEHAVIORALBreast Feeding AdherenceThis will be addressed according to the breastfeeding initiation practices according to the WHO.
BEHAVIORALFear of Covid-19 ScaleThe Fear of Covid-19 Scale is a questionnaire that evaluates fear of the global pandemic caused by the SARS-CoV-2. It consists of seven items, each with a five-point Likert scale of options. The participant is instructed to choose the option that best represents their perception about the statement presented. The maximum possible total is 35 points. The scale's authors indicate that the higher the score is, the higher is the level of the participants' fear of COVID-19.

Timeline

Start date
2021-01-01
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2021-02-24
Last updated
2023-10-02

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04769700. Inclusion in this directory is not an endorsement.